PM4800- A single or multiple visit protocol for collection of DNA/RNA/Serum/Plasma/CSF in Amyotrophic Lateral Sclerosis and Related Disorder
This study is a single visit followed by additional optional visits where samples will be collected and stored for future research. The research will be used to delineate vulnerability markers for disease, enhance the understanding of treatment response and side effects, and develop new drugs.
This trial is accepting new patients.
Basic Enrollment Criteria:
- Age 20-90 years old at onset of ALS
- Willing to comply with study visits and requirements